Status:
RECRUITING
Met Non Small Cell Cancer Registry (MOMENT)
Lead Sponsor:
EMD Serono Research & Development Institute, Inc.
Collaborating Sponsors:
Merck KGaA, Darmstadt, Germany
Conditions:
Cancer
Eligibility:
All Genders
Brief Summary
The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small c...
Detailed Description
This is a disease registry, which is an organized system using non-interventional methods to collect data on a patient population defined by a particular disease, exposure, or condition, and which is ...
Eligibility Criteria
Inclusion
- Participants who signed ICF
- Participants with advanced stage (stages IIIB-IV) NSCLC (all histologies) and Confirmed METex14 skipping alterations (by valid assay)
- Participants who are starting or are already being treated with systemic therapy
Exclusion
- Participants who are enrolled in a clinical trial
Key Trial Info
Start Date :
October 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 28 2028
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT05376891
Start Date
October 4 2022
End Date
April 28 2028
Last Update
November 12 2025
Active Locations (64)
Enter a location and click search to find clinical trials sorted by distance.
1
Holy Cross Health
Fort Lauderdale, Florida, United States, 33308-4603
2
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43221
3
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212
4
Klinikum Klagenfurt Am Woerthersee
Klagenfurt, Austria